Estimating the benefit of interferon therapy for individual patients with chronic hepatitis C.

被引：0
|
作者：
Yoshida, H
Tateishi, R
Arakawa, Y
Sata, M
Nishiguchi, S
Ishibashi, H
Fujiyama, S
Yamada, G
Yokosuka, O
Shiratori, Y
Omata, M
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Nihon Univ, Tokyo, Japan
[3] Kurume Univ, Kurume, Fukuoka 830, Japan
[4] Osaka City Univ, Osaka 558, Japan
[5] Nagasaki Med Ctr, Nagasaki, Japan
[6] Kumamoto Univ, Kumamoto 860, Japan
[7] Kawasaki Univ, Kawasaki Hosp, Okayama, Japan
[8] Chiba Univ, Chiba, Japan
[9] Okayama Univ, Okayama 7008530, Japan
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1005
引用
收藏
页码：641A / 641A
页数：1
相关论文
共 50 条
  • [21] Long-term outcome after interferon therapy in patients with chronic hepatitis C.
    Buti, Maria
    Esteban, Rafael
    ANNALS OF HEPATOLOGY, 2007, 6 (04) : 267 - 269
  • [22] The early phase response to interferon in patients with chronic hepatitis C.
    Hige, S
    Nagasaka, A
    Maruya, M
    Sasaki, Y
    Asaka, M
    Matsushima, T
    HEPATOLOGY, 1996, 24 (04) : 149 - 149
  • [23] Interferon therapy in patients with chronic hepatitis C and schistosomiasis
    Kamal, SM
    Madwar, MA
    Peters, T
    Fawzy, R
    Rasenack, J
    JOURNAL OF HEPATOLOGY, 2000, 32 (01) : 172 - 174
  • [24] Interferon therapy for serum HGV RNA positive chronic hepatitis C.
    Shibahara, N
    Moriyama, M
    Kasuya, A
    Matsumura, H
    Segawa, T
    Shimizu, T
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Abe, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1381 - A1381
  • [25] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [26] Long term effect of interferon therapy in children with chronic hepatitis C.
    Sawada, A
    Tajiri, H
    Tada, K
    Etani, Y
    Ozaki, Y
    Kozaiwa, K
    Okada, S
    Sako, M
    Kanesaki, T
    GASTROENTEROLOGY, 1996, 110 (04) : A1313 - A1313
  • [27] Improving persistency with combination interferon therapy for patients with hepatitis C.
    Golden, A
    Aubert, RE
    Dasmahapatra, A
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
  • [28] Apoptosis induction in PBMCs during interferon therapy for chronic hepatitis C.
    Wurzer, G
    Kobryn, T
    Ulbrich, G
    Watkins-Riedel, T
    Jessner, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    HEPATOLOGY, 2001, 34 (04) : 419A - 419A
  • [29] Interferon α, ribaivirin and amantadine combination is effective therapy for chronic hepatitis C.
    Sperl, J
    Hejtmankova, S
    Taimr, P
    Trunecka, P
    Honsova, E
    Spicak, J
    HEPATOLOGY, 2002, 36 (04) : 570A - 570A
  • [30] Evaluation of biological responders after interferon therapy with chronic hepatitis C.
    Tanaka, M
    Nishiguchi, S
    Enomoto, M
    Tanaka, T
    Minamitani, S
    Fukuda, K
    Tamori, A
    Habu, D
    Takeda, T
    Shiomi, S
    Seki, S
    Kuroki, T
    HEPATOLOGY, 1999, 30 (04) : 200A - 200A
12345